JCO Precision Oncology: Cell-Free DNA to Detect and Monitor Toxicity Signals

Tagomics’ Organ Health Programme Lead Dr John Gallon, Scientific Advisory Board member Professor Yuval Dor, and our partners at AstraZeneca have co-authored a paper recently published in JCO Precision Oncology exploring the next frontier in cfDNA applications: precision drug safety monitoring.